No abstract available
Keywords:
chronic kidney disease; economic analysis; progression of chronic renal failure.
Publication types
-
Editorial
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Cost-Benefit Analysis
-
Diabetes Mellitus, Type 2* / drug therapy
-
Glucosides / pharmacology
-
Glucosides / therapeutic use
-
Humans
-
Hypoglycemic Agents / therapeutic use
-
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
-
United States
Substances
-
Sodium-Glucose Transporter 2 Inhibitors
-
dapagliflozin
-
Glucosides
-
Hypoglycemic Agents